The CCT completed more than 200 successful Autologous Islet Transplantations since 2009. Islet autotransplantation can delay or prevent the onset of diabetes and improve patient quality of life.
The CCT provides access to highly trained and dedicated staff with expertise in all aspects of cellular therapy
The Center for Cellular Therapy (CCT) is an FDA registered cGMP level facility that meets the most rigorous standards in the aspect of processing of cells.
CCT offers a variety of immunomonitoring services. Customizable services range from processing and storage of patient samples for clinical trials to processing and analyzing human samples for research purposes.
Satish Nadig, M.D., Ph.D.
Shikhar Mehrotra, Ph.D.
Hongjun Wang, Ph.D.
Islet Program Coordinator: